PJP:NYE-Invesco Dynamic Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 88.5413

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

ETFs Containing PJP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.35% 90% A- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.35% 90% A- 70% C-
Trailing 12 Months  
Capital Gain 25.39% 76% C+ 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.39% 76% C+ 62% D
Trailing 5 Years  
Capital Gain 51.77% 81% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.77% 81% B- 72% C
Average Annual (5 Year Horizon)  
Capital Gain 6.65% 62% D 59% D-
Dividend Return 7.23% 62% D 54% F
Total Return 0.59% 58% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 12.98% 76% C+ 71% C-
Risk Adjusted Return 55.74% 76% C+ 72% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike